CLL Support Association

Heat Shock Protein Inhibitor (SNX-5422) and Ibrutinib

Don’t forget ibrutinib combined with a Heat Shock Protein Inhibitor (SNX-5422). There is a clinical trial going on now. (ID#NCT02973399).

Also, Cart T-Cell Therapy combined with ibrutinib.

If Car T-Cell Therapy with ROR1 as a target is effective, I would like to see a subsequent study combing it with Ibrutinib.

oldestnewest

You may also like...